HealthPolitics

The FDA’s Overton era, and dispatches from Shanghai

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 24/09/2026, 19:36:24 UTC.

Briefings

A 2026 podcast interview from Shanghai features Jason Mast and Margaret Manto discussing the potential impact of Chinese drug development on the biotech industry and the stability of the FDA's new commissioner, Heidi Overton. The hosts explore whether Overton's appointment will bring needed stability or controversy to the agency amid the broader context of the FDA's 'Overton era'.

Key points

• The podcast 'The Readout LOUD' is scheduled for international broadcast this week.
• Margaret Manto discusses the appointment of Heidi Overton as FDA commissioner to assess potential stability or controversy.

Context and limitations

Coverage is limited to the specific podcast interview and its discussion points regarding the FDA commissioner and Chinese drug development.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 24/09/2026, 19:37:13 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeifjwwsofz5pjzkobxl6s3ty5krolnoe2m4a6q3y3pp5ru6ehkciei